CTOs on the Move

EmanciCare

www.emancicare.com

 
EmanciCare is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Yes You Can!

YES YOU CAN!® A healthy lifestyle with a Latin Flavor.

Evolus

Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. At Evolus, you have the opportunity to be part of a movement. A performance beauty company changing the game. We are bringing innovation and forward-thinking technology to an industry desperately wanting frictionless experiences. Our work disrupts the status quo, but most importantly, we will make an impact, we are customer-centric - always. Because of this, we are excited to step through the door each morning. We help each other climb; we don`t climb over one another. We believe that integrity and a team-driven environment connect entrepreneurial minds. Getting goose bumps? Good. Join the Evolus movement, and let`s see where you can put your talents to work.

DSG

DSG develops software and service solutions for the clinical trial industry.

Persante Health Care

Persante Health Care is a national provider of sleep and balance center management services to hospitals, physician practices and patients. Persante`s expertise in sleep and balance related disorders dates back almost 20 years under the names of Sleep Care Centers, Sleep Tech, Mid-Atlantic School of Sleep Medicine and Blackwood Medical. The merging of these four unique industry leaders revolutionized the out-sourced delivery model of sleep and balance diagnosis and therapeutic treatment. This comprehensive approach to serving our client`s patients in a high quality manner has earned recognition and accreditation from The American Academy of Sleep Medicine and The National Sleep Foundation.

ASCENDIS PHARMA

Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.